3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Papillomavirus Infections
22
Uterine Cervical Neoplasms
18
Uterine Cervical Dysplasia
6
Condylomata Acuminata
6
Anus Neoplasms
5
Vulvar Neoplasms
4
Vaginal Neoplasms
3
HIV Infections
2
Whooping Cough
1
Virus Diseases
1
Tetanus
1
Persistent Infection
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
Neoplasm Metastasis
1
Meningitis
1
Lung Neoplasms
1
Keratosis, Actinic
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Genital Human Papilloma Virus Infection
1
Endometrial Neoplasms
1
Diphtheria
1
Crohn Disease
1
Colitis, Ulcerative
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Basal Cell
1
Acquired Immunodeficiency Syndrome
1
Interventions
Paclitaxel
95
Carboplatin
77
pembrolizumab
74
Cisplatin
29
Bevacizumab
27
Letrozole
22
Radiotherapy
21
Doxorubicin
21
Megestrol Acetate
20
lenvatinib
19
olaparib
18
Taxes
17
Docetaxel
17
Nivolumab
16
Specimen Handling
15
Metformin
15
dostarlimab
14
Magnetic Resonance Spectroscopy
14
Gemcitabine
13
durvalumab
12
Medroxyprogesterone Acetate
12
Trastuzumab
11
Indocyanine Green
11
Fulvestrant
11
Biopsy
11
temsirolimus
10
abemaciclib
10
atezolizumab
9
Radiation
9
Early Intervention, Educational
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Endometrial Neoplasms
×
Papillomavirus Vaccines
×
Clear all
NCT06686043
2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2
Recruiting
85 enrolled